Umbilical Vessel Catheters

Umbilical Vessel Catheters

Global Umbilical Vessel Catheters Market to Reach US$1.3 Billion by 2030

The global market for Umbilical Vessel Catheters estimated at US$863.5 Million in the year 2023, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Umbilical Vein Catheters (UVC), one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$747.7 Million by the end of the analysis period. Growth in the Umbilical Artery Catheters (UAC) segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$235.2 Million While China is Forecast to Grow at 9.7% CAGR

The Umbilical Vessel Catheters market in the U.S. is estimated at US$235.2 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$276.7 Million by the year 2030 trailing a CAGR of 9.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 4.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Umbilical Vessel Catheters Market - Key Trends and Drivers Summarized

Umbilical vessel catheters (UVCs) are critical medical devices used in neonatology to provide vascular access to newborns, especially those needing intensive care. These catheters are typically inserted into one of the two arteries or the vein in the umbilical cord stump, allowing for the administration of medications, fluids, and nutrients, as well as for the withdrawal of blood samples and monitoring of blood pressure. UVCs are particularly invaluable in the management of preterm infants or those with severe medical conditions immediately after birth. The proper placement and maintenance of these catheters are vital, as they help reduce the frequency of needle sticks in fragile infants and provide a lifeline during emergency situations. The design of umbilical vessel catheters has evolved to enhance safety and functionality, incorporating features that minimize the risk of infection, one of the primary complications associated with their use.

Advancements in the materials and technology used in the production of umbilical vessel catheters have significantly contributed to their effectiveness and safety. Modern UVCs are made from biocompatible materials that reduce the risk of thrombosis and vessel irritation, critical factors when dealing with the delicate vascular systems of newborns. Innovations such as catheters with anti-microbial coatings and those made from materials that can be more easily visualized under x-rays have further enhanced the utility and safety of these devices. Additionally, there has been a trend toward developing more specialized catheters designed for specific clinical situations, such as double or triple lumen catheters that allow multiple therapies simultaneously. These technological enhancements not only improve patient outcomes but also help streamline the workflow in neonatal intensive care units (NICUs), facilitating better care practices and reducing the time neonates need to spend in critical care.

The growth in the umbilical vessel catheters market is driven by several factors, including increasing rates of preterm births globally, advancements in neonatal care technologies, and heightened awareness of the benefits of specialized neonatal care devices. The rising incidence of preterm births necessitates effective interventions like UVCs that provide critical care at the earliest stages of life. As neonatal care standards continue to evolve, there is a growing demand for products that offer greater safety and efficiency, driving innovation and development in the market. Healthcare providers are increasingly adopting advanced, multifunctional catheters to improve the quality of care and outcomes for neonates in NICUs. Additionally, regulatory support for better healthcare facilities and the availability of technologically advanced medical devices are catalyzing the adoption of UVCs in emerging markets. Training programs for healthcare professionals on the latest neonatal care techniques also contribute to market growth by ensuring that the benefits of new catheter technologies are maximized. Collectively, these factors underscore the dynamic expansion of the umbilical vessel catheters market, reflecting ongoing improvements in neonatal medical care practices worldwide.

Select Competitors (Total 86 Featured) -

• Amecath Medical Technologies
• Angiplast Pvt Ltd.
• Cardinal Health, Inc.
• Footprint Medical, Inc.
• GPC Medical Ltd.
• Haolang Technology (Foshan) Limited Co., Ltd.
• Narang Medical Ltd.
• Ningbo GreatCare Trading Co., Ltd
• Pergomed
• Poly Medicure Limited
• Romsons Group of Industries
• Shree Umiya Surgical Pvt., Ltd. (Mediplus India)
• Sterimed Medical Devices Pvt. Ltd.
• SURU International Pvt. Ltd.
• Utah Medical Products, Inc.
• Vygon SA;

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.